The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer

Faculty Opinions recommendation of The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725298945.793503085 ◽

2015 ◽

Author(s):

Nico van Zandwijk

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Platinum Based Chemotherapy ◽

Egfr Tyrosine Kinase Inhibitors ◽

The Impact

Clinical Management of Non-Small Cell Lung Cancer with Concomitant EGFR Mutations and ALK Rearrangements: Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib

Targeted Oncology ◽

10.1007/s11523-019-00628-6 ◽

2019 ◽

Vol 14 (2) ◽

pp. 169-178 ◽

Cited By ~ 1

Author(s):

Yiming Zhao ◽

Shuyuan Wang ◽

Bo Zhang ◽

Rong Qiao ◽

Jianlin Xu ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Clinical Management ◽

Kinase Inhibitors ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

P2.03-002 Impact of EGFR-Tyrosine Kinase Inhibitors for Postoperative Recurrent Non-Small Cell Lung Cancer Harboring EGFR Mutations

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.1253 ◽

2017 ◽

Vol 12 (11) ◽

pp. S2127-S2128

Author(s):

S. Igawa ◽

Y. Sato ◽

S. Kusuhara ◽

S. Harada ◽

M. Shirasawa ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations

Oncology Research and Treatment ◽

10.1159/000455147 ◽

2017 ◽

Vol 40 (1-2) ◽

pp. 7-13 ◽

Cited By ~ 2

Author(s):

Satoshi Igawa ◽

Shiichiro Ryuge ◽

Masaaki Ichinoe ◽

Hiroyasu Nakashima ◽

Sakiko Otani ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations

OncoTargets and Therapy ◽

10.2147/ott.s106399 ◽

2016 ◽

pp. 3711 ◽

Cited By ~ 41

Author(s):

Jun Wang ◽

Baocheng Wang ◽

Huili Chu ◽

Yunfeng Yao

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Intrinsic Resistance ◽

Quantifying the sensitivities of EGF receptor (EGFR) tyrosine kinase inhibitors in drug resistant non-small cell lung cancer (NSCLC) cells using hydrogel-based peptide array

Biosensors and Bioelectronics ◽

10.1016/j.bios.2010.07.106 ◽

2010 ◽

Vol 26 (2) ◽

pp. 424-431 ◽

Cited By ~ 16

Author(s):

Gargi Ghosh ◽

Xiaoliang Yan ◽

Andrew G. Lee ◽

Stephen J. Kron ◽

Sean P. Palecek

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Egf Receptor ◽

Small Cell ◽

Peptide Array ◽

Drug Resistant ◽

Small Cell Lung ◽

Upfront Cranial Radiotherapy vs. EGFR Tyrosine Kinase Inhibitors Alone for the Treatment of Brain Metastases From Non-small-cell Lung Cancer: A Meta-Analysis of 1465 Patients

Frontiers in Oncology ◽

10.3389/fonc.2018.00603 ◽

2018 ◽

Vol 8 ◽

Cited By ~ 5

Author(s):

Xiao-Jing Du ◽

Su-Ming Pan ◽

Shu-Zhen Lai ◽

Xiao-Nan Xu ◽

Mei-Ling Deng ◽

...

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Cranial Radiotherapy ◽

Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors

Lung Cancer ◽

10.1016/j.lungcan.2019.10.029 ◽

2020 ◽

Vol 139 ◽

pp. 80-88 ◽

Cited By ~ 1

Author(s):

Yoshiya Matsumoto ◽

Kenji Sawa ◽

Mitsuru Fukui ◽

Jun Oyanagi ◽

Naoki Yoshimoto ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Low Frequency ◽

Small Cell ◽

Small Cell Lung ◽

T790m Mutation ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutated

Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR

Experimental Cell Research ◽

10.1016/j.yexcr.2014.02.026 ◽

2014 ◽

Vol 323 (2) ◽

pp. 288-296 ◽

Cited By ~ 26

Author(s):

Ki-Eun Hwang ◽

Su-Jin Kwon ◽

Young-Suk Kim ◽

Do-Sim Park ◽

Byoung-Ryun Kim ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

T790m Mutation ◽

Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors

Drug Discovery Today ◽

10.1016/j.drudis.2017.10.004 ◽

2018 ◽

Vol 23 (3) ◽

pp. 745-753 ◽

Cited By ~ 49

Author(s):

Mahaveer Singh ◽

Hemant R. Jadhav

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Small Molecule ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽